Medsider: Learn from Medtech and Healthtech Founders and CEOs
The Four-Risk Framework for Evaluating Medtech Opportunities: Interview with SonoVascular CEO Daniel Estay
Daniel Estay, CEO of SonoVascular, shares insights on evaluating the commercial viability of medtech opportunities using the Four-Risk Framework, covering technical, clinical, regulatory, and market risks. He also discusses strategic decisions regarding clinical trial sites and…